BLACK DIAMOND THERAPEUTICS I
BDTX · NASDAQ
Updated at 2026-10-13 15:06:24
- Today's High
- $1.77
- Today’s Low
- $1.68
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.86
- Previous Close
- $1.77
- Volume
- 377.69K
- Market Cap
- $101.69M
- P/E Ratio
- --
- EPS
- $-0.74
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 245 FIRST STREET, CAMBRIDGE, MA, UNITED STATES, 02142
- Country
- US
- Listing Date
- 2020-01-30
- Fiscal Year End
- December
- Shares Outstanding
- 57.3M
- CIK
- 0001701541
Black Diamond Therapeutics, Inc., a biotechnology company, discovers and develops small molecule tumor agnostic therapies. The company is headquartered in Cambridge, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$12.05M
2026-03-31
$11.25M
2025-12-31
$17.61M
2025-09-30
$10.97M
Net Income
2026-06-30
-$9.9M
2026-03-31
-$9.03M
2025-12-31
-$15.11M
2025-09-30
-$8.49M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.17
2026-03-31
$-0.16
2025-12-31
$-0.13
2025-09-30
$-0.15
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$13.25M
2026-03-31
-$9M
2025-12-31
-$10.19M
2025-09-30
-$8.41M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $12.05M | $11.25M | $17.61M | $10.97M |
| Net Income | -$9.9M | -$9.03M | -$15.11M | -$8.49M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.17 | $-0.16 | $-0.13 | $-0.15 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$13.25M | -$9M | -$10.19M | -$8.41M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.